Nevertheless, caution should be exercised in the progress of exosomal PD-L1 inhibitors for anti-cancer treatment, as exosomes have a significant impact on numerous physiological processes within the human body, and disrupting their release could lead to potential negative consequences. Here, CD274 is linked to cancer.